189 related articles for article (PubMed ID: 37495706)
1. Glioblastomas with and without peritumoral fluid-attenuated inversion recovery (FLAIR) hyperintensity present morphological and microstructural differences on conventional MR images.
Han Q; Lu Y; Wang D; Li X; Ruan Z; Mei N; Ji X; Geng D; Yin B
Eur Radiol; 2023 Dec; 33(12):9139-9151. PubMed ID: 37495706
[TBL] [Abstract][Full Text] [Related]
2. Ventricle contact is associated with lower survival and increased peritumoral perfusion in glioblastoma.
van Dijken BRJ; Jan van Laar P; Li C; Yan JL; Boonzaier NR; Price SJ; ; van der Hoorn A
J Neurosurg; 2018 Oct; 131(3):717-723. PubMed ID: 30485234
[TBL] [Abstract][Full Text] [Related]
3. Differentiating Glioblastoma from Primary Central Nervous System Lymphoma: The Value of Shaping and Nonenhancing Peritumoral Hyperintense Gyral Lesion on FLAIR Imaging.
Wang P; Shi YH; Li JY; Zhang CZ
World Neurosurg; 2021 May; 149():e696-e704. PubMed ID: 33548537
[TBL] [Abstract][Full Text] [Related]
4. Quantification of Radiomics features of Peritumoral Vasogenic Edema extracted from fluid-attenuated inversion recovery images in glioblastoma and isolated brain metastasis, using T1-dynamic contrast-enhanced Perfusion analysis.
Parvaze PS; Bhattacharjee R; Verma YK; Singh RK; Yadav V; Singh A; Khanna G; Ahlawat S; Trivedi R; Patir R; Vaishya S; Shah TJ; Gupta RK
NMR Biomed; 2023 May; 36(5):e4884. PubMed ID: 36453877
[TBL] [Abstract][Full Text] [Related]
5. Restriction Spectrum Imaging Improves Risk Stratification in Patients with Glioblastoma.
Krishnan AP; Karunamuni R; Leyden KM; Seibert TM; Delfanti RL; Kuperman JM; Bartsch H; Elbe P; Srikant A; Dale AM; Kesari S; Piccioni DE; Hattangadi-Gluth JA; Farid N; McDonald CR; White NS
AJNR Am J Neuroradiol; 2017 May; 38(5):882-889. PubMed ID: 28279985
[TBL] [Abstract][Full Text] [Related]
6. Analysis of heterogeneity of peritumoral T2 hyperintensity in patients with pretreatment glioblastoma: Prognostic value of MRI-based radiomics.
Choi Y; Ahn KJ; Nam Y; Jang J; Shin NY; Choi HS; Jung SL; Kim BS
Eur J Radiol; 2019 Nov; 120():108642. PubMed ID: 31546124
[TBL] [Abstract][Full Text] [Related]
7. Mesoscopic imaging of glioblastomas: Are diffusion, perfusion and spectroscopic measures influenced by the radiogenetic phenotype?
Demerath T; Simon-Gabriel CP; Kellner E; Schwarzwald R; Lange T; Heiland DH; Reinacher P; Staszewski O; Mast H; Kiselev VG; Egger K; Urbach H; Weyerbrock A; Mader I
Neuroradiol J; 2017 Feb; 30(1):36-47. PubMed ID: 27864578
[TBL] [Abstract][Full Text] [Related]
8. Predicting Glioblastoma Recurrence by Early Changes in the Apparent Diffusion Coefficient Value and Signal Intensity on FLAIR Images.
Chang PD; Chow DS; Yang PH; Filippi CG; Lignelli A
AJR Am J Roentgenol; 2017 Jan; 208(1):57-65. PubMed ID: 27726412
[TBL] [Abstract][Full Text] [Related]
9. Differentiation between glioblastomas and solitary brain metastases using diffusion tensor imaging.
Wang S; Kim S; Chawla S; Wolf RL; Zhang WG; O'Rourke DM; Judy KD; Melhem ER; Poptani H
Neuroimage; 2009 Feb; 44(3):653-60. PubMed ID: 18951985
[TBL] [Abstract][Full Text] [Related]
10. Pre- and post-contrast three-dimensional double inversion-recovery MRI in human glioblastoma.
Harris RJ; Cloughesy TF; Pope WB; Godinez S; Natsuaki Y; Nghiemphu PL; Meyer H; Paul D; Behbahanian Y; Lai A; Ellingson BM
J Neurooncol; 2013 Apr; 112(2):257-66. PubMed ID: 23344788
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686.
Boxerman JL; Zhang Z; Safriel Y; Rogg JM; Wolf RL; Mohan S; Marques H; Sorensen AG; Gilbert MR; Barboriak DP
Neuro Oncol; 2018 Sep; 20(10):1400-1410. PubMed ID: 29590461
[TBL] [Abstract][Full Text] [Related]
12. Multimodal imaging-defined subregions in newly diagnosed glioblastoma: impact on overall survival.
John F; Bosnyák E; Robinette NL; Amit-Yousif AJ; Barger GR; Shah KD; Michelhaugh SK; Klinger NV; Mittal S; Juhász C
Neuro Oncol; 2019 Feb; 21(2):264-273. PubMed ID: 30346623
[TBL] [Abstract][Full Text] [Related]
13. MR Imaging Characteristics Associate with Tumor-Associated Macrophages in Glioblastoma and Provide an Improved Signature for Survival Prognostication.
Zhou J; Reddy MV; Wilson BKJ; Blair DA; Taha A; Frampton CM; Eiholzer RA; Gan PYC; Ziad F; Thotathil Z; Kirs S; Hung NA; Royds JA; Slatter TL
AJNR Am J Neuroradiol; 2018 Feb; 39(2):252-259. PubMed ID: 29191871
[TBL] [Abstract][Full Text] [Related]
14. FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma.
Lohmann P; Stavrinou P; Lipke K; Bauer EK; Ceccon G; Werner JM; Neumaier B; Fink GR; Shah NJ; Langen KJ; Galldiks N
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):591-602. PubMed ID: 30327856
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of FLAIR Volume Changes in Glioblastoma and Prediction of Survival.
Grossman R; Shimony N; Shir D; Gonen T; Sitt R; Kimchi TJ; Harosh CB; Ram Z
Ann Surg Oncol; 2017 Mar; 24(3):794-800. PubMed ID: 27766560
[TBL] [Abstract][Full Text] [Related]
16. Radiomic features from the peritumoral brain parenchyma on treatment-naïve multi-parametric MR imaging predict long versus short-term survival in glioblastoma multiforme: Preliminary findings.
Prasanna P; Patel J; Partovi S; Madabhushi A; Tiwari P
Eur Radiol; 2017 Oct; 27(10):4188-4197. PubMed ID: 27778090
[TBL] [Abstract][Full Text] [Related]
17. A Neural Network Approach to Identify the Peritumoral Invasive Areas in Glioblastoma Patients by Using MR Radiomics.
Yan JL; Li C; van der Hoorn A; Boonzaier NR; Matys T; Price SJ
Sci Rep; 2020 Jun; 10(1):9748. PubMed ID: 32546790
[TBL] [Abstract][Full Text] [Related]
18. Evaluating angioarchitectural characteristics of glial and metastatic brain tumors with conventional magnetic resonance imaging.
Abecassis IJ; Cordy B; Durfy S; Andre JB; Levitt MR; Ellenbogen RG; Silbergeld DL; Ko AL
J Clin Neurosci; 2020 Jun; 76():46-52. PubMed ID: 32312627
[TBL] [Abstract][Full Text] [Related]
19. Sulcal hyperintensity on fluid-attenuated inversion recovery mr images in patients without apparent cerebrospinal fluid abnormality.
Taoka T; Yuh WT; White ML; Quets JP; Maley JE; Ueda T
AJR Am J Roentgenol; 2001 Feb; 176(2):519-24. PubMed ID: 11159107
[TBL] [Abstract][Full Text] [Related]
20. Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors.
Kubota T; Yamada K; Kizu O; Hirota T; Ito H; Ishihara K; Nishimura T
J Magn Reson Imaging; 2005 Jun; 21(6):694-700. PubMed ID: 15906343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
